Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-02-12

Clinical Trial Update: Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide [NA]

View source ↗

Summary

A completed clinical trial evaluated ipratropium bromide for treating clozapine-induced hypersalivation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Hypersalivation | NA | Status: COMPLETED